Life Technologies Corp. (LIFE) said Thursday that it has acquired Life Science Korea, an instrument distributor based in Seoul, South Korea.
Under the acquisition terms, the Life Science Korea name will become part of Life Technologies Korea. No other terms of the deal were disclosed.
Life Science Korea has been Life Technologies' primary instrument distributor since 1994 and holds distribution rights to Applied Biosystems products, including next-generation sequencing instruments, Sanger sequencing systems, forensics and PCR products. It serves more than 1,000 customers in academia, government, pharmaceutical, biotech, hospitals and applied markets.
"The acquisition of LSK is in line with our go-direct strategy in South Korea and builds on our current capabilities and platforms in this important market," said Mark Smedley, president of Life Technologies, Asia Pacific Japan region.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.